The therapeutic potential of TRPV1 (VR1) antagonists: Clinical answers await

Drug Discovery Today: Therapeutic Strategies

Volumn 1, Issue 1, 2004, Pages 97-104

  Rami, Harshad K ^a   Gunthorpe, Martin J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4(3H) QUINAZOLINONE DERIVATIVE; 5 IODORESINIFERATOXIN; ANANDAMIDE; ANTIINFLAMMATORY AGENT; AROMATIC AMINE; BENZIMIDAZOLE DERIVATIVE; CAPSAICIN; CAPSAICIN DERIVATIVE; CAPSAZEPINE; CARBOXYLIC ACID DERIVATIVE; CINNAMIC ACID DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; ISOQUINOLINE DERIVATIVE; MC 3116; NGX 4010; NONSTEROID ANTIINFLAMMATORY AGENT; OLVANIL; PAC 20030; PHOSPHONIC ACID DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDO[2,3 D]PYRIMIDIN 4(3H) ONE DERIVATIVE; QUINAZOLINE DERIVATIVE; RECEPTOR BLOCKING AGENT; RESINIFERATOXIN; SB 366791; SB 452533; SDZ 249665; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA DERIVATIVE; VANILLIN DERIVATIVE; VANILLOID RECEPTOR 1;

ASTHMA; CHRONIC INFLAMMATION; CLINICAL TRIAL; DRUG FORMULATION; DRUG INDUSTRY; DRUG MECHANISM; DRUG RESEARCH; HUMAN; IRRITABLE COLON; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN; REVIEW; SIDE EFFECT; SYSTEMIC DISEASE; URINE INCONTINENCE;

EID: 13444270763     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2004.08.020     Document Type: Review

References (28)

1. M.J. Caterina et al. The capsaicin receptor: A heat-activated ion channel in the pain pathway Nature 389 1997 816-824
2. D.E. Clapham et al. The TRP ion channel family Nat. Rev. Neurosci. 2 2001 387-396
3. M.J. Gunthorpe et al. The diversity in the vanilloid (TRPV) receptor family of ion channels Trends Pharmacol. Sci. 23 2002 183-191
4. P. Hayes et al. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1 Pain 88 2000 205-215
5. M.J. Caterina D. Julius The vanilloid receptor: A molecular gateway to the pain pathway Annu. Rev. Neurosci. 24 2001 487-517
6. P. Geppetti M. Trevisani Activation and sensitisation of the vanilloid receptor: Role in gastrointestinal inflammation and function Br. J. Pharmacol. 141 2004 1313-1320
7. A. Szallasi P.M. Blumberg Vanilloid (Capsaicin) receptors and mechanisms Pharmacol. Rev. 51 1999 159-212
8. M.J. Caterina et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor Science 288 2000 306-313
9. J.B. Davis et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia Nature 405 2000 183-187
10. C. Garcia-Martinez et al. Attenuation of thermal nociception and hyperalgesia by VR1 blockers Proc. Natl. Acad. Sci. USA 99 2002 2374-2379
11. J.D. Pomonis et al. N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain J. Pharmacol. Exp. Ther. 306 2003 387-393
12. K.M. Walker et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain J. Pharmacol. Exp. Ther. 304 2003 56-62
13. A. Szallasi C.J. Fowler After a decade of intravesical vanilloid therapy: Still more questions than answers Lancet Neurol. 1 2002 167-172
14. C.L. Chan et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency Lancet 361 2003 385-391
15. Y. Yiangou et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel Lancet 357 2001 1338-1339
16. H. Yamamoto et al. Effects of vanilloid receptor agonists and antagonists on gastric antral ulcers in rats Eur. J. Pharmacol. 432 2001 203-210
17. M.J. Carr et al. A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals J. Pharmacol. Exp. Ther. 304 2003 1275-1279
18. R.R. Ji et al. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia Neuron 36 2002 57-68
19. J.A. Karlsson et al. The role of capsaicin-sensitive C-fibre afferent nerves in the cough reflex Pulm. Pharmacol. 9 1996 315-321
20. S.W. Hwang U. Oh Hot channels in airways: Pharmacology of the vanilloid receptor Curr. Opin. Pharmacol. 2 2002 235-242
21. M.R. Zahner et al. Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats J. Physiol. 551 2003 515-523
22. S. Akerman et al. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors Br. J. Pharmacol. 2004 1354-1360
23. M.B. Chancellor W.C. de Groat Intravesical capsaicin and resiniferatoxin therapy: Spicing up the ways to treat the overactive bladder J. Urol. 162 1999 3-11
24. A. Szallasi G. Appendino Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? J. Med. Chem. 47 2004 2717-2723
25. H.K. Rami et al. Discovery of small molecule antagonists of TRPV1 Bioorg. Med. Chem. Lett. 14 2004 3631-3634
26. M.J. Gunthorpe et al. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist Neuropharmacology 46 2004 133-149
27. N.R. Gavva et al. Molecular determinants of vanilloid sensitivity in TRPV1 J. Biol. Chem. 279 2004 20283-20295
28. S.E. Jordt D. Julius Molecular basis for species-specific sensitivity to "hot" chili peppers Cell 108 2002 421-430